News and comments: Do aristolochic acids truly increase the occurrence of hepatocellular carcinoma?
Journal Title: Traditional Medicine Research - Year 2018, Vol 3, Issue 1
Abstract
Recently, Science Translational Medicine pointed out that 78% of the 98 hepatocellular carcinoma (HCC) samples from Taiwan, China, showed distinctive signatures of aristolochic acids (AAs) exposure. In addition, 47% of the HCC samples from mainland China, 29% from Southeast Asia, 13% from Korea, and 2.7% from Japan showed AA signatures, which is much higher than those in North America and Europe, by searching for the AAs signature in 1,400 HCC samples from around the world. Researchers have suggested that there is a distinct relationship between AAs and HCC occurrence in Asia. As soon as the news comes out, the medical community is immediately triggered. Does AAs truly cause the occurrence of HCC?
Authors and Affiliations
Editor Group of TMR, Xiong-Zhi Wu
Study on an innovative natural drug for Alzheimer's disease reported as a sham
The number of patients with dementia is estimated to be as high as 24 million and is predicted to double every 20 years, i.e., by 2040, leading to a tremendous financial disease burden [1]. Therefore, we urgently need to...
Under the narrative medicine theory to establish the evidence-based medical record written by doctors and patients through integrated therapy of traditional Chinese and western on digestive system diseases
Objective: The aim of this article was to discuss the theory of doctor-patient co-operated evidence-based medical record and set up the preliminary frame of the doctor-patient co-operated evidence-based medical record fo...
The regulation of method of tonifying Qi and activating blood circulation in the related gene expressions after spinal cord injury
The regulation of the genes including AQP4 gene, Bcl-2 gene, NF gene, Caspase gene, IL gene, NF-κB gene, TNF gene and HSP to treatment Spinal Cord Injury (SCI) by method of tonifying Qi and activating blood circulation w...
News and Comments: Have Phase Ⅲ clinical trials of Compound Danshen Dripping Pill “tragically failed”?
Compound Danshen Dripping Pill (CDDP) is the traditional Chinese medicine that has been widely used in China for the treatment of diseases such as coronary heart disease, stenocardia, and myocardial ischemia. The applica...
Pseudolaric acid B extracted from the Chinese medicinal herb Cortex Pseudolaricis ameliorates DNFB-induced atopic dermatitis-like skin lesions in BALB/c mice
Objective: Pseudolaric acid B (PB) is a newly identified diterpenoid isolated from Tujinpi (Cortex Pseudolaricis). In the present study, we aimed to explore the anti-inflammatory effects of PB on atopic dermatitis (AD),...